Follow-The-Filings

AIDX 20/20 Biolabs

20/20 Biolabs earnings company data as of 4:49 AM ET 10/4

History

2 periods · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS -0.12 — —
Rev — $700.0K —

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.07
8-K 3.01
8-K 7.01,9.01
8-K 5.07
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 2.02,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
10-Q QUARTERLY REPORT
8-K 7.01,9.01
8-K 1.01,3.01,9.01
8-K 7.01,9.01
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
8-K 3.03,5.03,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
8-K 2.02,9.01
10-Q QUARTERLY REPORT
8-K 1.01,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS
424B3 PROSPECTUS
S-1 REGISTRATION STATEMENT
8-K 2.02,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
4 Period Apr 2, 2026 · 2 forms
4 Period Mar 3, 2026
4 Period Feb 19, 2026 · 2 forms

2 more insider forms →

Consensus estimates · SEC filings remain the official record · not investment advice